Quantcast

Latest Fentanyl Stories

2014-04-01 16:25:48

CUPERTINO, Calif., April 1, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that data for POSIDUR((TM)) (SABER(®)-Bupivacaine), an investigational drug for administration into the surgical site to produce post-surgical analgesia, is being presented at the 39(th) Annual American Society of Regional Anesthetic and Pain Medicine Meeting. The meeting will be held on April 3-6 at the Sheraton Chicago Hotel and Towers in Chicago....

2014-03-14 08:26:42

BUNAVAIL PDUFA date June 7, 2014; Plans underway for potential Q3 2014 launch RALEIGH, N.C., March 14, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's 2013 financials and achievements as well as an update on business operations and upcoming milestones for...

2014-03-12 08:31:17

NEWARK, Calif., March 12, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that the U.S. Food and Drug Administration (FDA) approved Mallinckrodt plc's New Drug Application (NDA) for XARTEMIS(TM) XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), previously known as MNK-795, for the management of acute pain severe enough to require opioid treatment and in patients for whom alternative treatment options (e.g., non-opioid analgesics) are...

2014-03-10 16:33:25

NEWARK, Calif., March 10, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release fourth quarter fiscal year 2013 financial results after the market closes on Wednesday, March 12, 2014. The Company will host a conference call beginning at 4:30 pm Eastern time, 1:30 pm Pacific time to discuss its results. Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available...

2014-03-10 08:23:59

Novus Medical Detox warns the public of an emerging crisis--many addicted individuals are now turning to fentanyl-laced heroin, a choice that is costing some their lives. Novus pushes for comprehensive drug education and increasing access to detox and rehabilitation programs for drug users. NEW PORT RICHEY, Fla., March 10, 2014 /PRNewswire-iReach/ -- U.S. law enforcement and federal agencies alike have increasingly focused their attention on tackling the rise of drug addiction, but...

2014-03-06 23:01:24

The latest blog post from Per Wickstrom at PerWickstrom.com is focusing on a frightening drug that is making its way across the US and, particularly, the east coast in states like Maryland, Pennsylvania, New York, New Jersey and Rhode Island: “killer heroin.” (PRWEB) March 06, 2014 The latest blog post from Per Wickstrom at PerWickstrom.com is focusing on a frightening drug that is making its way across the US and, particularly, the east coast in states like Maryland, Pennsylvania,...

2014-03-05 16:26:21

NEWARK, Calif., March 05, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the 26th Annual ROTH Conference on Monday, March 10, 2014, at the Ritz Carlton in Dana Point, California. Depomed management is scheduled to present at 1:00 p.m. PT on Monday, March 10, with one-on-one meetings held throughout the day. A webcast of the presentation can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A...

2014-03-05 08:28:31

RALEIGH, N.C., March 5, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 26(th) Annual ROTH Conference. The presentation is scheduled for Monday, March 10, 2014 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) at the Ritz Carlton, Laguna Niguel in Dana Point, California. http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO The New Drug Application...

2014-02-28 08:24:51

RALEIGH, N.C., Feb. 28, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Cowen and Company 34(th) Annual Health Care Conference. The presentation is scheduled for Tuesday, March 4, 2014 at 8:40 a.m. Eastern Time at the Boston Marriott Copley Place. http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO BDSI submitted a New Drug Application (NDA) for...

2014-02-25 16:29:40

Company to present at upcoming RBC and Cowen investor conferences NEWARK, Calif., Feb. 25, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today reported preliminary financial results (unaudited) for the fourth quarter ended December 31, 2013 in anticipation of the company's upcoming presentations and live webcasts at the RBC Global Capital Markets Healthcare Conference and the Cowen & Co. Healthcare Conference. Preliminary (Unaudited) Fourth Quarter Financial Results Based on...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.